Reuters Health
NEW YORK (Reuters Health) - Use of metformin is associated with a
decreased risk of pancreatic cancer in patients with diabetics, new
research shows. By contrast, treatment with insulin or an insulin
secretagogue may increase the risk.
"The current study
demonstrated a robust protective effect of metformin against pancreatic
cancer in diabetes. Our major observations were that diabetics who ever
used metformin, especially those with greater than five years of use,
had a reduced risk of pancreatic cancer compared to diabetics who had
not taken these drugs," lead author Dr. Donghui Li said in a statement... Read More
Find a Doctor/Researcher
Make an Appointment
Refer a Patient
Make a Gift
Penn Cancer Network
